That these proteins are GSK3 substrates in NSCLC cells was confirmed in the A549 line in which GSK3α/β inhibitor CHIR99021 decreased the phosphorylation of all three substrates (Fig. 5B). This evidence concerns the gene GSK3A and non-small cell lung carcinoma.